Recently, the U.S. Food and Drug Administration (FDA), has begun to support the reporting and use of patient-reported outcome measures (PROMs) of symptoms as secondary end points in clinical trials for oncology treatment. These outcomes measures are likely to become increasingly important for oncology patients as they will hopefully become part of the drug label. [...]
All of the Americans who receive their insurance benefits from Medicare need to become aware that the Medicare Open Enrollment Period will begin this coming October 15. What is the Medicare open enrollment period?During this open enrollment period you can make new choices and pick plans that work best for you depending upon your doctors [...]
Prostate cancer can impact the quality of life, having a major effect on patients' day-to-day life and overall well-being. According to a new Canadian survey of men who have or have had prostate cancer, prostate cancer’s physical manifestations can also lead to psychological and social concerns, both of which are more pronounced for those with [...]
The state of cancer care is in crisis and getting worse. There is an ever growing demand for cancer care, a shrinking workforce, rising healthcare costs and an increasing complexity of treatment of cancer. According to the Institute of Medicine (IMO) cancer care in America is in a deep crisis! In analysing the current state [...]
On the advanced prostate cancer online support group there have been some questions raised about how we know when drugs like Zytiga and Xtandi have stopped working. Knowing this as soon as possible is important so that you can quickly move on to the next treatment without giving the prostate cancer time to progress and [...]
Someone on the advanced prostate cancer online support group ask about what are the criteria to go into hospice care. One individual replied that you would need to be within 6 months of your potential death. Another person replied from their individual experience. They said, “Hospice in CT doesn’t have a life expectancy strictly attached [...]
It was announced today by Dendreon Corp. that the European Commission (EC) has granted marketing authorization for Provenge in the European Union (EU) for the treatment of asymptomatic or minimally symptomatic metastatic (non-visceral) castrate resistant prostate cancer in male adults in whom chemotherapy is not yet clinically indicated. This final decision by the EC follows [...]
A post from Alan on the Advanced Prostate Cancer On-Line Support Group shared a link, which should interest all of us. It should interest us all because it will have an effect on each and every one of us, whether we are a prostate cancer survivor, if we become one in the future. Actually the [...]
Some bad news was reported today. Results from the Phase 3 randomized, double-blind clinical trial (Study 043) comparing Yervoy 10 mg/kg (ipilimumab) (n=399) to placebo (n=400) following radiation in men with advanced metastatic castration-resistant prostate cancer (mCRPC) who have received prior treatment with docetaxel showed no increase in overall survival. Yervoy is an immunotherapy which [...]
Mama might have been correct, eat your yogurt. Many of us already know that a healthy gut with plenty of probiotics to support your gastrointestinal health is absolutely critical to boosting your immune system. Experts say that gut flora could account for as much as 80% of our immune system! A study from the University [...]
